ISSN 1866-8836
Клеточная терапия и трансплантация
Change template to: full

Award Session: AW-01 – AW-04

AW-01. Transplantation of human hematopoietic stem cells with CCR5 knock out by CCR5-Uco-TALEN nuclease to NBSGW mice: pilot study

Yaroslava V. Komarova1, Alena I. Shakirova1, Vladislav S. Sergeev1, Svetlana A. Osipova2, Ekaterina V. Shchelina2, Anatoliya V. Onopchenko2, Marina L. Vasutina2, Olga G. Bredneva2, Kirill S. Yakovlev3, Yana R. Orshanskaya3, Konstantin V. Sivak3, Timofey E. Karpov1, Albert R. Muslimov1, Marina O. Popova1, Kirill V. Lepik1, Alexander D. Kulagin1

AW-02. Allogeneic hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas: a multicenter experience

Elena E. Lepik1, Vladislav V. Kovalik1, Andrey V. Kozlov1, Evgenia S. Borzenkova1, Kirill V. Lepik1, Elena V. Kondakova1, Nikita P. Volkov1, Vadim V. Baykov1, Marina O. Popova1, Ivan S. Moiseev1, Tatiana V. Shneider2, Olga S. Uspenskaya2, Marina V. Demchenkova3, Vera V. Sergeevicheva4, Vadim M. Kemaikin5, Gayane S. Tumyan6, Anastasia A. Semenova6, Ilya S. Zyuzgin7, Natalia B. Mikhailova1, Alexander D. Kulagin1

AW-03. Prophylactic and preventive therapy with azacitidine and donor lymphocyte infusions after allo-HSCT in children with acute myeloid leukemia

Liubov A. Tsvetkova, Olesya V. Paina, Zhemal Z. Rakhmanova, Anna A. Osipova, Polina V. Kozhokar, Аnastasia S. Frolova, Elena V. Semenova, Alexander D. Kulagin, Ludmila S. Zubarovskaya

AW-04. Optimization of aseptic care techniques for central venous catheter in patients with hematological diseases

Tamara A. Gogoleva                                              

Acute leukemias: AL-01 – AL-10

AL-01. First experience in diagnosis and treatment of Philadelphia chromosome-like acute lymphoblastic leukemia

Kseniia S. Afanaseva, Polina V. Sheveleva, Olga V. Pirogova, Anna G. Smirnova, Olesya V. Paina, Ildar M. Barkhatov, Tatiana L. Gindina, Elena V. Babenko, Ivan S. Moiseev, Sergey N. Bondarenko, Ludmila S. Zubarovskaya, Alexander D. Kulagin

AL-02. Treatment options for adult patients with refractory/relapsed acute myeloid leukemia

Bella I. Ayubova1, Sergey N. Bondarenko1, Ivan S. Moiseev1, Anna G. Smirnova1, Olga S. Uspenskaya2, Elena V. Karyagina3, Evgenia I. Zhelnova4, Elena V. Babenko1, Ildar M. Barkhatov1, Tatyana L. Gindina1, Alexander D. Kulagin1

AL-03. Gilteritinib as a bridge to allogeneic hematopoietic stem cell transplantation in adult patients with refractory/relapsed acute myeloid leukemia with FLT3 mutations

Bella I. Ayubova1, Sergey N. Bondarenko1, Anna G. Smirnova1, Yulia Yu. Vlasova1, Nikolay Yu. Tsvetkov1, Michail M. Kanunnikov1, Dmitry K. Zhogolev1, Yuliya D. Oleynikova1, Elena V. Karyagina2, Ridvan K. Ilyasov3, Natalya A. Zorina4, Svetlana S. Belyaeva5, Yulia S. Neredko6, Irina A. Samorodova7, Yulia B. Chernih8, Mikhail Yu. Lazarev9, Anna P. Kochergina10, Anna A. Nasredinova1, Ildar M. Barkhatov1, Tatyana L. Gindina1, Ivan S. Moiseev1, Alexander D. Kulagin1

AL-04. Midostaurin in adult patients with de novo diagnosed FLT3-positive acute myeloid leukemia

Sergey N. Bondarenko1, Anna G. Smirnova1, Bella I. Ayubova1, Yulia Y. Vlasova1, Elena V. Karyagina2, Olga S. Uspenskaya3, Yulia S. Neredko4, Elena A. Pashneva5, Anna P. Kochergina6, Natalia B. Esefyeva7, Tatyana I. Brazkina8, Ridvan K. Ilyasov9, Yulia B. Chernih10, Yurii A. Dunaev11, Irina A. Samorodova12, Olesia G. Smykova1, Ksenia S. Yurovskaya1, Dmitrii K. Zhogolev1, Michail M. Kanunnikov1, Yulia D. Oleynikova1, Ildar M. Barkhatov1, Tatiana L. Gindina1, Ivan S. Moiseev1, Alexander D. Kulagin1

AL-05. First results of the “Cooperative Program for Diagnosis and Treatment of Acute Myeloid Leukemia in Russian Federation” implementation

Sergey N. Bondarenko1, Dmitrii K. Zhogolev1, Bella I. Ayubova1, Anna G. Smirnova1, Tatiana L. Gindina1, Elena V. Babenko1, Ildar M. Barkhatov1, Natalia E. Ivanova1, Tatiana S. Shchegoleva1, Veronika V. Ermolina1, Nikita P. Volkov1, Varvara I. Bakhtina2, Natalya N. Glonina3, Ksenia S. Dedyukhina4, Yuri A. Dunaev5, Tatiana S. Kaporskaya6, Elena G. Kirillova7, Vladimir A. Kobiyasov8, Tatiana S. Konstantinova9, Marina V. Kosinova10, Tatiana I. Ksenzova11, Alexander A. Myasnikov12, Irina A. Novokreshenova13, Olesya S. Kuznetsova14, Tatiana I. Olkhovik15, Elena A. Pashneva16, Anastasia G. Petukhova17, Andrey V. Proydakov18, Kirill V. Rytov19, Victoria V. Ryabchikova20, Irina A. Samorodova20, Olga S. Samoilova21, Irina V. Trukhan22, Ekaterina A. Ukrainchenko23, Olga S. Uspenskaya24, Maria V. Frolova25, Yuri V. Shatokhin26, Rada H. Ebzeeva27, Angelina V. Talko28, Konstantin P. Novoselov29, Alina G. Karpova30, Ivan S. Moiseev1, Alexander D. Kulagin1

AL-06. Influence of allogeneic hematopoietic stem cell transplantation on the treatment outcomes in patients with Ph-positive acute B-lymphoblastic leukaemia

Valeriia C. Luchkina, Olga A. Aleshina, Zalina T. Fidarova, Larisa A. Kuzmina, Galina A. Isinova, Ekaterina S. Kotova, Anastasia N. Vasileva, Sergey N. Bondarenko, Valerii A. Lapin, Zalina Kh. Akhmerzaeva, Mikhail Y. Drokov, Vera V. Troitskaya, Elena N. Parovichnikova

AL-07. Modern approaches to predicting post-transplant relapse of acute myeloid leukemia in children

Zhemal Z. Rakhmanova, Olesya V. Paina, Ildar M. Barkhatov, Ilya V. Kazantsev, Ayrat M. Sadykov, Svetlana V. Razumova, Polina V. Kozhokar, Anastasiya S. Frolova, Liubov A. Tsvetkova, Elena V. Babenko, Tatyana L. Gindina, Alexander L. Alyanskiy, Elena V. Semenova, Ludmila S. Zubarovskaya

AL-08. Heterogeneity of t(10;11) translocation with KMT2A-MLLT10 molecular product in patients with acute myeloid leukemia

Maria V. Stegantseva1, Darya R. Kapuza1, Julia A. Barouskaya1, Maria G. Naumovich1, Veronika А. Astramovich1, Olga V. Aleinikova2

AL-09. The experience with asciminib as a bridge- therapy before allogeneic bone marrow transplantation

Yulia Yu. Vlasova, Elena V. Morozova, Ksenia S. Yurovskaya, Tatiana A. Rudakova, Tatiana L. Gindina, Ildar M. Barkhatov, Ivan S. Moiseev, Alexander D. Kulagin

AL-10. Clinical features of cytokine release syndrome in adult patients with acute leukemia after allogeneic stem cell transplantation: RM Gorbacheva Research Institute experience

Nikita P. Volkov, Julia V. Kotova, Maria D. Vladovskaya, Jaroslav B. Skiba, Dmitrii K. Zhogolev, Kseniia S. Afanaseva, Yulia Yu. Vlasova, Sergey N. Bondarenko, Marina O. Popova, Yuliya A. Rogacheva, Ivan S. Moiseev

Lymphomas: LY-01 – LY-08

LY-01. Myeloid-derived supressor cells and their suppressive potential after autologous hematopoietic stem cell transplantation in patients with multiple myeloma

Tatyana A. Aristova, Tamara V. Tyrinova, Egor V. Batorov, Vera V. Denisova, Svetlana A. Sizikova, Galina Yu. Ushakova, Ekaterina Y. Shevela, Alexander A. Ostanin, Elena R. Chernykh

LY-02. Treatment strategy of patients with relapsed and refractory aggressive B-cell non-Hodgkin lymphoma

Liudmila V. Fedorova, Olesya G. Smykova, Andrey M. Chekalov, Marina O. Popova, Vladislav V. Markelov, Elena V. Kondakova, Ivan S. Moiseev, Kirill V. Lepik, Natalia B. Mikhailova, Alexander D. Kulagin

LY-03. Long-term multicenter study of nivolumab efficacy and safety in patients with relapsed and refractory classic Hodgkin lymphoma

Yaroslava V. Komarova1, Ludmila V. Fedorova1, Marina V. Demchenkova2, Maria V. Grigorieva2, Polina V. Kotselyabina1, Andrey M. Chekalov1, Elena E. Lepik1, Elena V. Kondakova1, Evgenia S. Borzenkova1, Vadim V. Baykov1, Marina O. Popova1, Ivan S. Moiseev1, Kirill V. Lepik1, Natalia B. Mikhailova1, Alexander D. Kulagin1

LY-04. Prospective study: autologous hematopoietic stem cell transplantation in patients with HIV-related lymphoma

Marina O. Popova, Yuliya A. Rogacheva, Andrey M. Chekalov, Ivan V. Tsygankov, Kirill V. Lepik, Lilia V. Stelmakh, Vadim V. Baykov, Natalia B. Mikhailova, Alexander D. Kulagin

LY-05. Comparison of toxicity and efficacy of BeEAC, LEAM, and CLV conditioning regimens before autologous stem cell transplantation for treatment of primary-refractory and relapsed forms of Hodgkin’s lymphoma

Anastasiia A. Samoylova, Vladislav O. Sarzhevskiy, Vladimir Ya. Melnichenko, Nikita E. Mochkin, Anatoliy A. Rukavitsyn, Elena G. Smirnova, Vladimir S. Bogatyrev, Anna E. Bannikova

LY-06. Quality control of peripheral hematopoietic blood stem cells transplants obtained by G-CSF and plerixafor-induced mobilization in patients with multiple myeloma

Zarui K. Simavonyan, Anait D. Davtyan, Irina V. Kobzeva, Tatiana A. Astrelina, Yuliya B. Suchkova, Elena K. Sokolova

LY-07. Immunochemotherapy with nivolumab, bendamustine, gemcitabine and rituximab (BeGeRN) in relapsed or refractory B-cell Non-Hodgkin Lymphoma: NCT03259529

Olesya G. Smykova, Vladislav V. Markelov, Kirill V. Lepik, Elena V. Kondakova, Lilia V. Stelmakh, Ivan S. Moiseev, Natalia B. Mikhailova, Alexander D. Kulagin

LY-08. First-line therapeutic strategy and clinical prognosis in the patients with marginal zone lymphoma: Pavlov University experience

Lina B. Surina, Polina V. Kotselyabina, Kirill V. Lepik, Elena V. Kondakova, Liudmila V. Fedorova, Marina O. Popova, Natalia B. Mikhailova, Alexander D. Kulagin

Chronic hematological malignancies: CM-01 – CM-05

CM-01. Comparison of prognosis between patients with therapy-related myelodysplastic syndrome after hematological malignancies and myelodysplastic syndrome de novo: retrospective cohort study

Polina V. Kotselyabina, Vladislav V. Kovalik, Vladislav V. Markelov, Nikita N. Burlov, Kirill V. Lepik, Natalia B. Mikhailova, Olga B. Kalashnikova, Nikolay Y. Tsvetkov, Ksenia S. Yurovskaya, Tatiana L. Gindina, Ivan S. Moiseev, Alexander D. Kulagin, Elena V. Morozova

CM-02. Inflammatory cytokines perturb NK cell cytotoxicity and gene signature in myeloid leukemia

Valeriya V. Kuznetsova, Amanda F. Costa, Sweta B. Patel, Francesca Luca, Victoria R. Matkins, Alana M. Franceski, Paran Goel, Robert S. Welner

CM-04. Characteristics and treatment of blast crisis in chronic myeloid leukemia

Julia S. Yakovleva, Ksenia S. Yurovskaya, Yulia Yu. Vlasova, Ivan S. Moiseev, Elena V. Morozova

CM-05. Determining predictors of unfavorable course in low- and intermediate-risk patients with myelodysplastic syndrome

Ksenia S. Yurovskaya, Elena V. Morozova, Maria V. Barabanshchikova, Nikolay Y. Tsvetkov, Yulia Yu. Vlasova, Tatiana L. Gindina, Ildar M. Barkhatov, Ivan S. Moiseev, Alexander D. Kulagin

Hematopoiesis failure, anemias: HA-01 – HA-05

HA-02. Genetic mutations in children with acquired aplastic anemia

Irma V. Yemialyanova, Tatiana А. Uglova, Alexander А. Migas, Olga V. Aleinikova

HA-03. Allo-HSCT in sickle cell anemia and thalassemia: a case presentation

Lusine M. Krmoyan1, Mane S. Gizhlaryan1, Karen H. Meliksetyan1, Narine A. Ghazaryan1, Dianna R. Soghomonyan1, Nelli O. Musayelyan1, Armine A. Pepanyan1, Andranik G. Shamilyan1, Vahe A. Mayilyan1, Inga V. Khalatyan1, Taguhi J. Hovhannisyan1, Melanya S. Sahakyan1, Emma Tadevosyan1, Gevorg N. Tamamyan1, Samvel H. Danielyan1, Lawrence Faulkner2

HA-04. Effects of immunopeptidome diversity on the development of graft failure in patients with acute leukemia

Feruza A. Omarova, Mikhail Yu. Drokov, Ekaterina G. Khamaganova, Natalia N. Popova, Olga S. Starikova, Ulyana V. Maslikova, Zoya V. Konova, Elmira I. Kolgaeva, Ekaterina D. Mikhaltsova, Mariya V. Dovydenko, Olga M. Koroleva, Anna A. Dmitrova, Darya S. Dubnyak, Mobil I. Akhmedov, Vera A. Vasilyeva, Larisa A. Kuzmina, Elena N. Parovichnikova

HA-05. Long-term results of immunosuppressive therapy in patients with aplastic anemia

Irina A. Tsopova, Erbol M. Sadabaev, Sagynaly M. Mamatov, Irina E. Kononets

Immune complications: IC-01 – IC-05

IC-01. The role of NK-cells associated factors in outcomes of haploidentical hemopoietic stem cells transplantation performed after selective depletions

Svetlana Yu. Glushkova, Viktoria A. Vedmedskaya, Dmitriy E. Pershin, Yakov O. Muzalevskii, Alexei S. Kazachenok, Elena E. Kurnikova, Svetlana A. Radygina, Maria A. Ilushina, Rimma D. Khismatullina, Larisa N. Shelikhova, Dmitriy E. Balashov, Alexei A. Maschan, Michael A. Maschan

IC-02. The use of ruxolitinib in combination with extracorporeal photopheresis in patients with steroid-refractory acute and chronic graft-versus-host disease

Nune A. Kambaryan, Anna A. Dotsenko, Tatiana A. Bykova, Yulia Yu. Vlasova, Anna A. Osipova, Olesya V. Paina, Anna G. Smirnova, Elena V. Morozova, Ludmila S. Zubarovskaya, Ivan S. Moiseev

IC-03. Combination of bendamustine and cyclophosphamide in graft-versus-host disease prophylaxis in refractory myeloid neoplasms: promising approach to augmentation of graft-versus-leukemia effect

Ivan S. Moiseev, Yulia Yu. Vlasova, Elena V. Morozova, Olga S. Epifanovskaya, Ksenia S. Afanaseva, Anastasia V. Beynarovich, Dmitry K. Zhogolev, Mikhail M. Kanunnikov, Yulia A. Rogacheva, Tatiana N. Rudakova, Nikita P. Volkov, Sergey N. Bondarenko, Alexander D. Kulagin

IC-04. Comparison of different T-helper cell populations in patients with and without chronic graft-versus-host disease after allo-HSCT for acute leukemia

Olga S. Starikova, Mikhail Y. Drokov, Nikolai M. Kapranov, Irina V. Galtseva, Ekaterina G. Khamaganova, Ksenia A. Nikiforova, Yulia O. Davydova, Vera A. Vasilyeva, Ekaterina D. Mikhaltsova, Natalia N. Popova, Daria S. Dubnyak, Anna A. Dmitrova, Olga M. Koroleva, Zoya V. Konova, Mobil I. Akhmedov, Maria V. Dovydenko, Uliana V. Maslikova, Feruza A. Omarova, Elmira I. Kolgaeva, Mironova D.A., Inara S. Saidullaeva, Luiza A. Karaseva, Larisa A. Kuzmina, Elena N. Parovichnikova, Valery G. Savchenko

IC-05. Ruxolitinib as a treatment of steroid-refractory acute and chronic graft-versus-host disease in children

Anna A. Zvyagintseva, Ivan S. Moiseev, Tatyana A. Bykova, Olesya V. Paina, Anna A. Osipova, Ludmila S. Zubarovskaya

Posttransplant infections: PI-01 – PI-08

PI-01. Invasive fungal diseases of the maxillofacial region, nasal cavity and paranasal sinuses in hematological patients and patients with post-COVID syndrome

Irina B. Baranova1,2, Andrey I. Yaremenko1, Marina O. Popova2, Yulia A. Rodneva2,3, Oleg I. Dolgov2,3, Anna A. Zubareva3, Ilya Yu. Nikolaev2, Olga N. Pinegina5, Margarita V. Malyarevskaya6, Sergey A. Karpishchenko3, Аlena N. Zaitseva2, Alexander N. Shvetsov2, Тatyana А. Bykovа2, Olesya V. Paina2, Oleg V. Goloshchapov2, Sergey N. Bondarenko2, Ludmila S. Zubarovskaya2, Nikolay N. Klimko4, Alexander D. Kulagin2

PI-02. Conducting allo-HSCT in children under the conditions of COVID-19 pandemic

Natalia P. Gusleva, Olga O. Molostova, Olga V. Pimenova, Larisa N. Shelikhova, Michael A. Maschan

PI-03. Invasive aspergillosis in patients with hematological malignancies due to cryptic pathogens

Vladislav V. Markelov1, Marina O. Popova1, Yuliya A. Rogacheva1, Olga N. Pinegina1, Alisa G. Volkova1, Ilia Y. Nikolaev1, Nikita P. Volkov1, Tatiana S. Bogomolova2, Oleg V. Goloshchapov1, Olesya V. Paina1, Yulia Yu. Vlasova1, Sergey N. Bondarenko1, Nikolay N. Klimko1,2, Ludmila S. Zubarovskaya1, Alexander D. Kulagin1

PI-04. Sepsis in early post-transplant period: new approaches to treatment

Nune V. Matinyan, Tatyana V. Gorbunova, Timur T. Valiev, Irina O. Kostareva, Timur. Z. Aliev, Natalya A. Burlaka, Natalya A. Batmanova,Vasiliy P. Akimov, Elena G. Gromova, Kirill I. Kirgizov, Svetlana R. Varfolomeeva

PI-05. Invasive fusariosis in patients with hematological and oncohematological diseases

Olga N. Pinegina1, Marina O. Popova2, Yuliya A. Rogacheva2, Irina B. Baranova2, Yulia A. Rodneva2, Alisa G. Volkova2, Ilya Yu. Nikolaev2, Alena N. Zaitseva2, Alexander N. Shvetsov2, Stanislav D. Gorbunkov3, Anna A. Spiridonova1, Oleg V. Goloshchapov2, Tatyana A. Bykova2, Bella I. Ayubova2, Maria V. Bogomolova2, Andrey L. Akopov3, Ludmila S. Zubarovskaya2, Sergey N. Bondarenko2, Alexander D. Kulagin2

PI-06. Surgical experience in the treatment of invasive fungal disease of upper respiratory tract in hematological patients and patients who have a new coronavirus infection caused by SARS-CoV-2

Yulia A. Rodneva1,3, Irina B. Baranova1,4, Marina O. Popova1, Ilya Yu. Nikolaev1, Olga N. Pinegina1, Oleg I. Dolgov1,3, Maksim A. Kondrashov1, Alyona N. Zaitseva1, Alexander N. Shvetsov1, Tatyana A. Bykova1, Olga V. Panina1, Oleg V. Goloshchapov1, Sergey N. Bondarenko1, Ludmila S. Zubarovskaya1, Nikolay N. Klimko1,2, Sergey A. Karpishchenko3, Andrey I. Yaremenko4, Kirill A. Ekushov1, Alexander D. Kulagin1

PI-07. Detection frequency of herpesviruses in colonic mucosal biopsies in the patients with intestinal complications after hematopoietic stem cell transplantation

Alexander N. Shvetsov, Oleg V. Goloshchapov, Alexei B. Chukhlovin, Anna A. Spiridonova, Maria D. Vladovskaya, Ludmila S. Zubarovskaya, Alexander D. Kulagin

PI-08. Detecting mycoplasma contamination of cell cultures by means of digital drop-PCR

Irina A. Sidorova, Alena I. Shakirova, Timofey E. Karpov, Yaroslava V. Komarova, Kirill V. Lepik, Alexander D. Kulagin

Pediatric oncology: PO-01 – PO-07

PO-01. Hematopoietic stem cell transplantation in rare pediatric cancers and hematological conditions: the N. N. Blokhin National Medical Research Center of Oncology experience

Teymur Z. Aliev, Irina O. Kostareva, Nara G. Stepanyan, Natalia A. Burlaka, Karina A. Sergeenko, Yuri V. Lozovan, Elena B. Machneva, Olga A. Kapkova, Amina M. Suleimanova, Tatiana L. Ushakova, Marina V. Rubanskaya, Natalia A. Batmanova, Timur T. Valiev, Anatoly P. Kazantsev, Vladimir G. Polyakov, Kirill I. Kirgizov, Svetlana R. Varfolomeeva

PO-02. The first St. Petersburg experience of using total body irradiation as part of conditioning regimes prior to allogeneic hematopoietic stem cells transplantation in children

Maria A. Rusina1, Yulia V. Dinikina1, Alexey V. Mikhailov2,3, Svetlana I. Lapaeva1, Anna Yu. Smirnova1, Andrey S. Egorov1, Yulia K. Toshina1, Daria A. Morgacheva1, Nikolay A. Vorobyov2,4, Nikita A. Kataev2, Anton V. Kubasov2

PO-03. Specific characteristics of donor blood transfusions in pediatrics

Elvira A. Gasanova, Polina S. Kuga, Olga F. Slesarchuk, Maxim A. Kucher

PO-04. Impact of patients’ age on the treatment adherence in allo-HSCT recipients

Elmira I. Kolgaeva, Mikhail Y. Drokov, Dmitri E. Vybornykh, Larisa A. Kuzmina, Elena N. Parovichnikova

PO-05. Outcomes of allogeneic hematopoietic stem cell transplantation for children, adolescents, young adults with acute lymphoblastic leukemia at the Center for Pediatric Oncology, Hematology and Immunology

Dmitry V. Prudnikov, Natalia P. Kirsanova, Yulia E. Mareiko, Olha A. Mishkova, Aleksey V. Alekseychik, Mariya G. Naumovich, Nina V. Minakovskaya

PO-06. Immune checkpoint inhibitors in pediatric Hodgkin lymphoma

Sabina V. Ryabenko, Andrey V. Kozlov, Asmik G. Gevorgyan, Ilya V. Kazantsev, Natalya B. Mikhailova, Ludmila S. Zubarovskaya

PO-07. Outcomes of second hematopoietic stem cell transplantation in children with malignant and non-malignant blood disorders: a single center study

Larisa V. Vakhonina1,2, Anna A. Vlasova1,2, Dmitry E. Klevakin1,2, Grigory A. Tsaur1,2, Tatiana Yu. Verzhbitskaya1,2, Anna S. Demina1,2, Larisa G. Fechina1,2

Posttransplant care and rehabilitation: PC-01 – PC-03

PC-02. Early rehabilitation of patients at the oncology department

Alexey A. Safronov1, Oksana V. Koryakina2, Konstantin E. Klevakin3

PC-03. Some features of nasogastric tube installation and care in cancer patients

Natalya G. Saltykova, Maxim A. Kucher, Alexander D. Kulagin

Gene and cellular therapy: GC-01 – GC-07

GC-01. Anti-CD19 CAR T-cell therapy in Belarus: Current state

Elena S. Lukojko1, Alexandr A. Migas1, Tatsiana V. Shman1, Igor N. Severin2, Olga A. Kalenik2, Natalya N. Konoplia2, Inna V. Proleskovskaya1, Olga V. Aleinikova3

GC-02. Resistance to anti-CD19 CAR T-cell therapy. Case report

Alexandr A. Migas1, Tatsiana V. Shman1, Anna V. Klych1, Elena S. Lukojko1, Evgeniy V. Dmitriev1, Lyudmila V. Movchan1, Mikalai A. Katsin3, Inna V. Proleskovskaya1, Olga V. Aleinikova2

GC-03. Lentiviral transduction efficiency of natural killer cells

Anastasia S. Mukhametshyna, Alexander A. Migas, Tatsiana V. Shman

GC-04. Studies on therapeutic potential of a radiopharmaceutical based on polymer capsules with incorporated 188Re isotope for the treatment of inflammatory joint diseases

Alisa S. Postovalova1,2, Timofey E. Karpov1,2, Nikolay A. Kostenikov2, Dmitry S. Sysoev2, Dmitry O. Antuganov2, Darya R. Akhmetova1,2, Albert R. Muslimov1, Alexander S. Timin1,2

GC-05. Improving the efficiency of long targeted insertions into the human cell genome using the TALEN editing platform and non-viral delivery techniques for gene therapy of socially significant diseases

Alena I. Shakirova, Timofei E. Karpov, Yaroslava V. Komarova, Olga S. Epifanovskaya, Vladislav S. Sergeev, Marina O. Popova, Kirill V. Lepik, Alexander D. Kulagin

GC-06. In silico study of mutagenic effect of NCSTN gene in development of bone marrow neoplasms

Bogdan O. Shcheglov                                     

GC-07. Production of injectable implant mesenchymal stem cells for treatment of osteoarthritis

Hanna A. Zhernasechanka1, Yanina I. Isaikina1, Dzmitry V. Bukach2

Organizational issues, donorship: OID-01 – OID-07

OID-01. Probability of viral hepatitis markers detection in potential hematopoietic stem cell donors

Liudmila N. Bubnova, Tatiana A. Matveeva, Irina E. Pavlova, Tatiana V. Glazanova

OID-02. Analysis of factors able to influence the bloodborne infections’ markers positivity rate

Tatiana V. Gaponova, Dmitry S. Tikhomirov, Kristina V. Shaidurova, Tatiana A. Tupoleva

OID-03. Arranging bone marrow donor registry in Sakha Republic (Yakutia)

Vilena V. Gerasimova1,2, Nadezhda V. Savvina2, Aitalina S. Golderova2

OID-04. Immunogenetic profile of the Russian and Belarusian hematopoietic stem cells donors registries

Ludmila N. Bubnova1, Elena V. Kuzmich1, Alena V. Hlaz2, Irina E. Pavlova1, Maria A. Terentyeva1, Anatoly L. Uss2, Ihar A. Iskrou2, Siarhei P. Liashchuk2

OID-05. Arrangement of the blood donor registry typed for the red blood cell antigens

Natalia V. Mineeva, Svetlana V. Gavrovskaya, Irina I. Krobinets, Elena A. Sysoeva, Natalia N. Bodrova